{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:06:45Z","timestamp":1778126805645,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1124\/mol.115.102731","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T05:51:05Z","timestamp":1463637065000},"page":"80-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mechanisms of Action of Novel Influenza A\/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride"],"prefix":"10.1016","volume":"90","author":[{"given":"Pouria H.","family":"Jalily","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodene","family":"Eldstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon S. -H.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Tietjen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fedida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.115.102731_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.03253-14","article-title":"Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface","volume":"89","author":"Alvarado-Facundo","year":"2015","journal-title":"J Virol"},{"key":"10.1124\/mol.115.102731_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bi901799k","article-title":"Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel","volume":"49","author":"Balannik","year":"2010","journal-title":"Biochemistry"},{"key":"10.1124\/mol.115.102731_bib3","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"},{"key":"10.1124\/mol.115.102731_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055271","article-title":"Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay","volume":"8","author":"Balgi","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.115.102731_bib5","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/jvi.62.5.1508-1512.1988","article-title":"Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection","volume":"62","author":"Belshe","year":"1988","journal-title":"J Virol"},{"key":"10.1124\/mol.115.102731_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1124\/mol.115.102731_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1113\/jphysiol.1996.sp021495","article-title":"Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells","volume":"494","author":"Chizhmakov","year":"1996","journal-title":"J Physiol"},{"key":"10.1124\/mol.115.102731_bib8","unstructured":"Ewart GD, Luscombe CA, and Miller M (2009) inventors, Biotron Limited, assignee. Hepatitis c antiviral compositions and methods. U.S. patent WO2009018609A1. Aug 4, 2008."},{"key":"10.1124\/mol.115.102731_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s002490100177","article-title":"Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu","volume":"31","author":"Ewart","year":"2002","journal-title":"Eur Biophys J"},{"key":"10.1124\/mol.115.102731_bib10","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1124\/mol.115.102731_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.drudis.2012.05.002","article-title":"Viral targets of acylguanidines","volume":"17","author":"Gazina","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1124\/mol.115.102731_bib12","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J"},{"issue":"Suppl B","key":"10.1124\/mol.115.102731_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/18.Supplement_B.19","article-title":"Molecular basis of resistance of influenza A viruses to amantadine","volume":"18","author":"Hay","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/mol.115.102731_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semiempirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.115.102731_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01308-09","article-title":"Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages","volume":"54","author":"Khoury","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.115.102731_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01871102","article-title":"Amiloride and its analogs as tools in the study of ion transport","volume":"105","author":"Kleyman","year":"1988","journal-title":"J Membr Biol"},{"key":"10.1124\/mol.115.102731_bib17","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/jm500598u","article-title":"Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A","volume":"57","author":"Kolocouris","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/mol.115.102731_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.antiviral.2010.02.312","article-title":"A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-\u03b1-2b and nucleoside analogues","volume":"86","author":"Luscombe","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1124\/mol.115.102731_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.115.102731_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1534-5807(03)00190-4","article-title":"Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes","volume":"5","author":"Mould","year":"2003","journal-title":"Dev Cell"},{"key":"10.1124\/mol.115.102731_bib21","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.115.102731_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro2820","article-title":"Viroporins: structure and biological functions","volume":"10","author":"Nieva","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/mol.115.102731_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.bbamem.2013.09.004","article-title":"The minimalist architectures of viroporins and their therapeutic implications","volume":"1838","author":"OuYang","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.115.102731_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature12283","article-title":"Unusual architecture of the p7 channel from hepatitis C virus","volume":"498","author":"OuYang","year":"2013","journal-title":"Nature"},{"key":"10.1124\/mol.115.102731_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000511","article-title":"Structure and inhibition of the SARS coronavirus envelope protein ion channel","volume":"5","author":"Pervushin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1124\/mol.115.102731_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1124\/mol.115.102731_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(03)01453-4","article-title":"Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride","volume":"557","author":"Premkumar","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.115.102731_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/mol.115.102731_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1124\/mol.115.102731_bib30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"Stouffer","year":"2008","journal-title":"Nature"},{"key":"10.1124\/mol.115.102731_bib31","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1990.tb07555.x","article-title":"Specific structural alteration of the influenza haemagglutinin by amantadine","volume":"9","author":"Sugrue","year":"1990","journal-title":"EMBO J"},{"key":"10.1124\/mol.115.102731_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbamem.2010.04.008","article-title":"Minimal art: or why small viral K(+) channels are good tools for understanding basic structure and function relations","volume":"1808","author":"Thiel","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.115.102731_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.115.102731_bib34","doi-asserted-by":"crossref","first-page":"12834","DOI":"10.1021\/ja204969m","article-title":"Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2","volume":"133","author":"Wang","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1124\/mol.115.102731_bib35","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jm301538e","article-title":"Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus","volume":"56","author":"Wang","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/mol.115.102731_bib36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nsmb.1707","article-title":"Solution structure and functional analysis of the influenza B proton channel","volume":"16","author":"Wang","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/mol.115.102731_bib37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.115.102731_bib38","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1021\/ja4041412","article-title":"Drug-induced conformational and dynamical changes of the S31N mutant of the influenza M2 proton channel investigated by solid-state NMR","volume":"135","author":"Williams","year":"2013","journal-title":"J Am Chem Soc"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24004723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24004723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.115.102731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:14:30Z","timestamp":1739960070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24004723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0026895X24004723"],"URL":"https:\/\/doi.org\/10.1124\/mol.115.102731","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of Action of Novel Influenza A\/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.115.102731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}